Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Akiva Mozes, Ziv Kop, Heidi Melin

Premium

The agricultural genomics firm Evogene has appointed Akiva Mozes and Ziv Kop to serve on its board of directors.

Mozes is chairman of Bazan Group's Oil Refinery, a member of the board of directors of Strauss Group, and he formerly was president and CEO of Israel Chemicals.

Kop is the founder and CEO of Go Capital, and he formerly was managing partner at Glenrock Israel and CEO of POC management consulting.


Accelrys said this week that its stockholders have elected Heidi Melin to serve on its board of directors until 2016. Melin is the chief marketing officer of Plex Systems, and she formerly was senior VP and chief marketing officer at Eloqua. She also worked in marketing and management at Taleo, Polycom, Hyperion, and Peoplesoft.

She will serve on the Accelrys board's human resources committee and governance and nominating committee.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more